All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

/images/Cortellis_Flagship_Logo_TM_RGB_Color.png
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • Diagnosing and tracking COVID-19
    • Drugs to Watch 2020
    • The next pandemic
    • Premium reports
      • BioWorld Financings Reports
      • Disease Forecast Reports

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, March 2, 2021
Home » Blogs » BioWorld MedTech Perspectives » Ditching Medicare: Maybe crazy, but tougher than you think

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

BioWorld MedTech / Medicare

Ditching Medicare: Maybe crazy, but tougher than you think

Feb. 12, 2012
By Mark McCarty
No Comments

Whaddaya, nuts or somethin'?

There are many definitions for the word “crazy,” and here's another. Crazy is when you want to get out of Medicare and save the government and the taxpayer money, but the government won't let you.

Recent reports indicate that a group of five senior citizens, including former Texas Republican congressman Dick Armey, are okay with their Social Security benefits, but that the law is forcing them to enroll in Medicare Part A if they want to stay on Social Security.

The case made it to the Court of Appeals for the District of Columbia, and maybe the fact that the case was in DC should have tipped everyone off. After all, DC is the jurisdiction that passed a law stating that the city's rats could not be killed, but had to be trucked 25 miles away from the city and released on the unsuspecting citizens of Virginia and Maryland.

In any event, Judges Brett Kavanaugh and Douglas Ginsburg are said to have told the five seniors, “we're sorry. We get it, but the law doesn't.”

Between Medicare and Social Security, Medicare is expected to cost much more in the years to come, but instead of allowing retirees to take just Social Security and leave the Medicare money on the table, everyone has to take both or neither.

One might assume there is no mass exodus from Medicare among impending retirees, but what sane person would take Medicare over private insurance? Let's assume one of every 10 Baby Boomers can stay on their private insurance for the rest of their lives. If you assume there are 78 million Boomers, that's 7.8 million who might forswear Medicare.

According to the Kaiser Family Foundation, the average Medical cost per beneficiary is more than $8,300, and Kaiser also suggests that Part A accounted for 41% of Medicare spending in 2007. That would come to roughly $3,300 per year. Multiply that average cost by 7.8 million and you get how much in savings by dropping this requirement?

About $25.6 billion per year, that's how much. But even if only 5% of Boomers could carry private insurance until death do part them from this world, that's more than $12 billion a year. If you assume those Boomers will last about 20 years after retirement, hardly a stretch of the imagination according to CDC, we're talking $120 billion at least, maybe $250 billion.

Whichever number you choose, that's a lot of money. It might not be enough to fix the Medicare financing mess, but there is no one adjustment that will. But hey, let's not mess with success, shall we? Government rules are what got us here, so why not roll with it?

Oh yeah, another definition of crazy? Doing the same thing over and over again and expecting a different outcome. Now that's just crazy.

You must login or register in order to post a comment.

Report Abusive Comment

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 1.
  • Gloved hand places sample tubes in PCR system

    COVID-19 test makers are adapting for variants

    BioWorld MedTech
    As COVID-19 variants have emerged, so have questions about the effectiveness of tests for infection. While the risk of mutations significantly limiting their...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for March 2.
  • Celltrion-Regkirona-2-9

    Celltrion wins first conditional Korean approval for COVID-19 antibody Regkirona

    BioWorld
    HONG KONG – Celltrion Inc. has received conditional marketing authorization from the Ministry of Food and Drug Safety (MFDS) for its anti-COVID-19 monoclonal...
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • About
    • Archives
    • Today's news
    • Search BioWorld Science
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
A Clarivate Analytic solution. Link to Clarivate website.
Follow Us

Copyright ©2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing